These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 23166018)
1. Generating extracellular amyloid aggregates using E. coli cells. Sivanathan V; Hochschild A Genes Dev; 2012 Dec; 26(23):2659-67. PubMed ID: 23166018 [TBL] [Abstract][Full Text] [Related]
2. Conversion of a yeast prion protein to an infectious form in bacteria. Garrity SJ; Sivanathan V; Dong J; Lindquist S; Hochschild A Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10596-601. PubMed ID: 20484678 [TBL] [Abstract][Full Text] [Related]
7. Impact of Amyloid Polymorphism on Prion-Chaperone Interactions in Yeast. Killian AN; Miller SC; Hines JK Viruses; 2019 Apr; 11(4):. PubMed ID: 30995727 [TBL] [Abstract][Full Text] [Related]
8. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Derkatch IL; Uptain SM; Outeiro TF; Krishnan R; Lindquist SL; Liebman SW Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12934-9. PubMed ID: 15326312 [TBL] [Abstract][Full Text] [Related]
9. How Do Yeast Cells Contend with Prions? Wickner RB; Edskes HK; Son M; Wu S; Niznikiewicz M Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635197 [TBL] [Abstract][Full Text] [Related]
10. The physical dimensions of amyloid aggregates control their infective potential as prion particles. Marchante R; Beal DM; Koloteva-Levine N; Purton TJ; Tuite MF; Xue WF Elife; 2017 Sep; 6():. PubMed ID: 28880146 [TBL] [Abstract][Full Text] [Related]
11. [Modification of [PSI+] prion properties by the combination of amino acid changes within Sup35 protein N-domain]. Bondarev SA; Shirokolobova ED; Trubitsyna NP; Zhuravleva GA Mol Biol (Mosk); 2014; 48(2):314-21. PubMed ID: 25850301 [TBL] [Abstract][Full Text] [Related]
12. Sequestration of Sup35 by aggregates of huntingtin fragments causes toxicity of [PSI+] yeast. Zhao X; Park YN; Todor H; Moomau C; Masison D; Eisenberg E; Greene LE J Biol Chem; 2012 Jul; 287(28):23346-55. PubMed ID: 22573320 [TBL] [Abstract][Full Text] [Related]
13. Nucleation seed size determines amyloid clearance and establishes a barrier to prion appearance in yeast. Villali J; Dark J; Brechtel TM; Pei F; Sindi SS; Serio TR Nat Struct Mol Biol; 2020 Jun; 27(6):540-549. PubMed ID: 32367069 [TBL] [Abstract][Full Text] [Related]
14. Glycosylphosphatidylinositol anchoring directs the assembly of Sup35NM protein into non-fibrillar, membrane-bound aggregates. Marshall KE; Offerdahl DK; Speare JO; Dorward DW; Hasenkrug A; Carmody AB; Baron GS J Biol Chem; 2014 May; 289(18):12245-63. PubMed ID: 24627481 [TBL] [Abstract][Full Text] [Related]
17. Human J-protein DnaJB6b Cures a Subset of Saccharomyces cerevisiae Prions and Selectively Blocks Assembly of Structurally Related Amyloids. Reidy M; Sharma R; Roberts BL; Masison DC J Biol Chem; 2016 Feb; 291(8):4035-47. PubMed ID: 26702057 [TBL] [Abstract][Full Text] [Related]
19. Growth phase-dependent changes in the size and infectivity of SDS-resistant Sup35p assemblies associated with the [PSI Wang K; Melki R; Kabani M Mol Microbiol; 2019 Sep; 112(3):932-943. PubMed ID: 31206803 [TBL] [Abstract][Full Text] [Related]
20. Molecular basis for transmission barrier and interference between closely related prion proteins in yeast. Afanasieva EG; Kushnirov VV; Tuite MF; Ter-Avanesyan MD J Biol Chem; 2011 May; 286(18):15773-80. PubMed ID: 21454674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]